Objective: To explore the current situation,hot frontier and development trend of diabetic nephropathy nursing. Methods: The relevant literature of diabetic nephropathy nursing from built database of Web of Science Core Collection to July 11,2021 were searched,and the research object and research frontiers were analyzed by CiteSpaceⅴsoftware. Results: A total of 1 049 articles were included in this paper. Bibliometric analyzed that the annual number of articles in this field showed a trend of slow fluctuation,and the number of articles published in 2020 was 105, and the top 5 articles with high citation have been cited 470 times,451 times, 427 times,368 times and 362 times,respectively. Keywords cluster analyzed that sodium-glucose cotransporter 2 inhibitor,proteinuria,and stage renal disease were the main concerns of the academic community. New hypoglycemic drugs,inflammation and pathogenesis were the research frontiers in this field. Conclusion: Through literature visualization analysis,this paper clearly shows the current situation of research in the field of diabetic nephropathy nursing,and provides intuitive reference data for further studying diabetic nephropathy and comprehensive management strategies in the future.
ZHANG Ying
,
ZHENG Jing
,
XU Jjuan
,
GUAN Yuxiang
. Knowledge map and visualization analysis of diabetic nephropathy nursing research based on CiteSpace[J]. Journal of Baotou Medical College, 2022
, 38(12)
: 61
-66
.
DOI: 10.16833/j.cnki.jbmc.2022.12.013
[1] Umanath K, Lewis JB.Update on diabetic nephropathy: core curriculum 2018[J].Am J Kidney Dis, 2018, 71(6): 884-895.
[2] Sun H, Saeedi P, Karuranga S, et al.IDF diabetes atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045[J].Diabetes Res Clin Pract, 2022, 183(1): 119-125.
[3] Selby NM, Taal MW.An updated overview of diabetic nephropathy: Diagnosis, prognosis, treatment goals and latest guidelines[J].Diabetes Obes Metab, 2020, 22(Suppl.1): 13-15.
[4] Doshi SM, Friedman AN.Diagnosis and management of type 2 diabetic kidney disease[J].Clin J Am Soc Nephrol, 2017, 12(8): 1366-1373.
[5] 贺小宁, 张雅雯, 阮贞, 等.中国2型糖尿病患者慢性并发症患病率与次均医疗费用研究[J].中华内分泌代谢杂志, 2019, 35(3): 200-205.
[6] Chen, C. CiteSpaceⅡ: Detecting and visualizing emerging trends and transient patterns in scientific literature[J].J Am Soc Inf Sci Technol, 2006, 57(3): 359-377.
[7] Van Dieren S, Beulens JW, Vander Schouw YT, et al.The global burden of diabetes and its complications: an emerging pandemic[J].Eur J Cardiovasc Prev Rehabil, 2010, 17(Suppl.1): S3-S8.
[8] Mann JFE, Orsted DD, Buse JB.Liraglutide and renal outcomes in type 2 diabetes[J].N Engl J Med, 2017, 377(22): 2197-2198.
[9] Tuttle KR, Bakris GL, Bilous RW, et al.Diabetic kidney disease: a report from an ADA Consensus Conference[J].Diabetes Care, 2014, 37(10): 2864-2883.
[10] Groop PH, Thomas MC, Moran JL, et al.The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes[J].Diabetes, 2009, 58 (7): 1651-1658.
[11] Haroun MK, Jaar BG, Hoffman SC, et al.Risk factors for chronic kidney disease: a prospective study of 23, 534 men and women in Washington County, Mary land[J].J Am Soc Nephrol, 2003, 14(11): 2934-2941.
[12] Kim YC, Shin N, Lee S, et al.Effect of post-transplant glycemic control on long-term clinical outcomes in kidney transplant recipients with diabetic nephropathy: A multicenter cohort study in Korea[J].PLoS One, 2018, 13(4): e0195566.
[13] Nanwani B, Shankar P, Kumar R, et al.Risk factors of diabetic foot amputation in pakistani type II diabetes individuals[J].Cureus, 2019, 11(6): e4795.
[14] Ahola AJ, Harjutsalo V, Forsblom C, et al.Depression is associated with progression of diabetic nephropathy in type 1 diabetes[J].Diabetes Care, 2021, 44(1): 174-180.
[15] Gebre BB, Anand S, Assefa ZM.Depression and its predictors among diabetes mellitus patients attending treatment in hawassa university comprehensive specialized hospital, southern ethiopia[J].J Diabetes Res, 2020, 22(2): e7138513.
[16] 中华医学会肾脏病学分会专家组.糖尿病肾脏疾病临床诊疗中国指南[J].中华肾脏病杂志, 2021, 37(2): 255-304.
[17] Kravets I, Mallipattu SK.The role of podocytes and podocyte-associated biomarkers in diagnosis and treatment of diabetic kidney disease[J].J Endocr Soc, 2020, 4(4): bvaa029.
[18] Kawaguchi H, Moriyama M, Hashimoto H.Does disease management for diabetic nephropathy reduce medical expenditure? Evidence from a three-period difference-in-differences analysis[J].BMC Health Serv Res, 2020, 20(1): 403.
[19] Lewinski AA, Patel UD, Diamantidis CJ, et al.Addressing diabetes and poorly controlled hypertension: pragmatic mHealth self-management intervention[J].J Med Internet Res, 2019, 21(4): e12541.
